Φορτώνει......
Receptor Tyrosine Kinase-Targeted Cancer Therapy
In the past two decades, several molecular targeted inhibitors have been developed and evaluated clinically to improve the survival of patients with cancer. Molecular targeted inhibitors inhibit the activities of pathogenic tyrosine kinases. Particularly, aberrant receptor tyrosine kinase (RTK) acti...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Mol Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6274851/ https://ncbi.nlm.nih.gov/pubmed/30404198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19113491 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|